Please provide your email address to receive an email when new articles are posted on . “A significant percentage of [chronic spontaneous urticaria (CSU)] patients don’t respond to antihistamines,” ...

Spotify Technology SA will begin testing a new feature that allows users to type an idea for a playlist into the app and receive a unique set of songs based on their historical taste and behavior. The ...

This is read by an automated voice. Please report any issues or inconsistencies here. Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...

Threads is testing a new way for users to manipulate their own recommendation algorithm. The feature, aptly called "Dear algo," allows users to post a message to the algorithm with the note "dear algo ...

Fatigue, joint pain, rashes, brain fog or tingling in the hands and feet can seem like normal signs of aging—but they may also point to an autoimmune disease. These potentially disabling and often ...

Konig and Green are among the champions of this effort which The AP calls "a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus, and other devastating autoimmune ...

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases — by reprogramming patients' out-of-whack immune ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. There's PBC, there's PSC, and then there's ...

What’s happened? Instagram is testing a new feature that gives users more control over the type of content they see on the platform. Why is this important? Instagram’s algorithm plays a major role in ...

Instagram is rolling out a new test that lets select users fine-tune what they’d like to see in their Reels and Explore feeds. Here’s what it looks like. Instagram lead Adam Mosseri took to Threads ...

Evidence is emerging that amyotrophic lateral sclerosis (ALS) may have an autoimmune component — a finding that, if confirmed, could shape the development of new therapies and prognostic tools.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...